The protective effect of dammarane sapogenin protopanaxadiol on muscle atrophy after peripheral nerve injury

Featured Articles


082

Recent advances in ginseng as cancer therapeutics: a functional and mechanistic overview

0 0 The first issue of Natural Product Reports in 2015 will publish a comprehensive review regarding ginseng’s anti-cancer effects and underlying mechanisms. Here we summarize this review as follows:...

Protopanaxadiol

Pharmacological Review of Ginsenoside Dammarane Saponin Rh2

3 0 Please download here. Related PostsAntiallergic activity of ginsenoside Rh2 Rb1 prevents osteoporosis by inhibiting osteoclastogenesis PPD induces apoptosis of glioma cells Rh2 improves insulin sensitivity Antiestrogenic effect of...

081

Pharmacological Review of Ginsenoside Dammarane Saponin Rg1

0 0 Please download here. Related PostsRb1 prevents inflammation and apoptosis in human articular chondrocytes Anti-arthritic effect of ginsenoside Rb1 PPT improves hematopoiesis in myelosuppression mice Rh2 induces β-cell regeneration...

042

Pharmacological Review of Ginsenoside Dammarane Saponin Rb1

0 0 Please download here. Related PostsGinsenoside Rb1 attenuates activated microglia-induced brain damage Ginsenoside Rb1 prevents neuronal injury and stimulates growth of axons and dendrites Protective effects of ginsenoside Rb1...

029

Pharmacological Review of Aglycon Dammarane Sapogenin (AGS) – Protopanaxatriol (PPT)

0 0 Please download here. Related PostsGinsenoside Rb1 improves postoperative fatigue syndrome Ginsenoside rb1 protects the heart from hypoxia/ischemia Ginsenosides Rg1 and Rb1 are the major ingredients of Fufang Danseng...

006

Pharmacological Review of Aglycon Dammarane Sapogenin (AGS) – Protopanaxadiol (PPD)

0 0 Please download here.   Related PostsDripping pill can be an effective drug delivery method for oral dammarane sapogenins Ginsenosides Rg1 activates neural stem cells Immunomodulation by ginsenoside Rg1...

008

Antiallergic activity of ginsenoside Rh2

0 0 The antiallergic activities of ginsenosides, which were isolated from acid-treated ginseng (Panax ginseng, Araliaceae), and their metabolites by human intestinal bacteria were measured. Ginsenoside Rh2, which is a...

107

Rb1 prevents osteoporosis by inhibiting osteoclastogenesis

0 0 Ginsenosides, the main active components of ginseng, have been reported possessing anti-osteoporosis activity in ovariectomized rats. However, the active ingredient and the mechanisms underlying the anti-osteoporosis activity of...

028

PPD induces apoptosis of glioma cells

0 0 20S-Protopanaxadiol (PPD) is an aglycon metabolic derivative of the protopanaxadiol-type ginseng saponins. In the present study, PPD was used to induce cytotoxicity for two human glioma cell lines,...

132

Rh2 improves insulin sensitivity

0 0 Ginsenoside Rh2, one of the ginsenosides contained in the Panax ginseng root, was employed to screen the effect on insulin resistance of rats induced by a diet containing...

Down
pause
Up

 

0
0



In North America, data taken from a trauma population in Canada revealed that approximately 2-3% of patients had a major nerve injury. In New South Wales, Australia, 2% of patients were reported to have a major nerve injury. Peripheral nerve injuries may result in loss of motor function, sensory function, or both. If the peripheral nerve can not be re-connected, long-term denervation (loss of nerve supply) can cause muscle atrophy (a partial or complete wasting away of muscle).

In the early stages following peripheral nerve injury, physical therapy is started to maintain passive range of motion in the affected joints and to maintain muscle strength in the unaffected muscles. However, the functional recovery is not always satisfactory.

Protopanaxatriol (PPT) is a dammarane-type tetracyclic terpene sapogenin found in ginseng (Panax ginseng) and in notoginseng (Panax pseudoginseng), and it has pleiotropic pharmacological effects, including bone marrow stimulation, immune respnse enhancement, anti-inflammation, etc.

Interestingly, the muscle loss might be prevented, or at least slowed, by the use of protopanaxatriol, reported by a study published on Journal of Jilin University (Medicine Edition) 2010, 36(1).

The study replicated the peripheral nerve injury (sciatic nerve severance) in Wistar rats, which was then treated with protopanaxatriol-type saponins intramuscularly at either 25 mg/kg or 50 mg/kg for 24 weeks. Also, ATP was adminstered as the positive control. After the nerve injury, the muscle mass, cross-sectional area of the muscle, and the diameter of muscle fibers decreased gradually over time. At 16 weeks, a less reduction in above parameters was observed in both PPT and ATP treatments. However, the positive effect of ATP faded away at 20 weeks, by when the beneficial effect of PPT at both doses on the muscle still remained. Compared to the control, PPT treatment could also slow down the loss of motor plate, a terminal structure by which a motor neuron establishes contact with a muscle fiber.

Overall, PPT can protect muscle wasting after peripheral nerve injury, and may give rist to a better recovery of motor function if used with surgical repair.

The protective effect of dammarane sapogenin protopanaxadiol on muscle atrophy after peripheral nerve injury
0 votes, 0.00 avg. rating (0% score)

读者同时也阅读了...


Hit Counter provided by laptop reviews